Copyright
©2010 Baishideng Publishing Group Co.
World J Cardiol. Jul 26, 2010; 2(7): 205-210
Published online Jul 26, 2010. doi: 10.4330/wjc.v2.i7.205
Published online Jul 26, 2010. doi: 10.4330/wjc.v2.i7.205
Table 3 Hemodynamics and angiographic results (mean ± SE)
Variables | MS group | Non-MS group | ||
Value | % change | Value | % change | |
Baseline mean blood pressure (mmHg) | 111 ± 2a | 104 ± 2 | ||
Baseline heart rate (/min) | 67 ± 2 | 64 ± 1 | ||
Coronary diameter (mm) | ||||
Baseline | 3.26 ± 0.11 | 0 | 3.11 ± 0.07 | 0 |
ACh at 3 μg/min | 3.30 ± 0.12 | 1.6 ± 1.4 | 3.18 ± 0.08 | 2.6 ± 0.7 |
ACh at 30 μg/min | 3.23 ± 0.13 | -0.5 ± 1.9 | 3.08 ± 0.09 | -0.5 ± 1.3 |
Nitroglycerin | 3.67 ± 0.12 | 13.9 ± 2.3 | 3.54 ± 0.08 | 14.7 ± 1.6 |
Coronary blood flow (mL/min) | ||||
Baseline | 77 ± 6 | 0 | 65 ± 4 | 0 |
ACh at 3 μg/min | 110 ± 14 | 38 ± 9b | 114 ± 9 | 73 ± 6 |
ACh at 30 μg/min | 137 ± 20a | 82 ± 18d | 190 ± 13 | 198 ± 12 |
Coronary flow reserve | 3.3 ± 0.2 | 3.6 ± 0.1 |
- Citation: Teragawa H, Mitsuba N, Nishioka K, Ueda K, Kono S, Higashi Y, Chayama K, Kihara Y. Impaired coronary microvascular endothelial function in men with metabolic syndrome. World J Cardiol 2010; 2(7): 205-210
- URL: https://www.wjgnet.com/1949-8462/full/v2/i7/205.htm
- DOI: https://dx.doi.org/10.4330/wjc.v2.i7.205